CTRI/2020/07/026534尚未招募3 期
Evaluation of clinical efficacy of antiviral nutraceutical PICOVRID in COVID-19 positive patients
Indian Institute of Technology Bombay0 个研究点目标入组 0 人开始时间: 待定最近更新:
试验速览
- 阶段
- 3 期
- 状态
- 尚未招募
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1. Individuals COVID-19 positive in last 3 days
- •2. Patients with mild COVID-19 illness as defined in the MOHFW guidelines i.e. fever and or upper respiratory tract infection ,influenza like illness
- •3. Patients agreeing to provide a written informed consent
- •4. Patients who agree to reside in the COVID 19 facility during the study
排除标准
- •1. Patients with moderate or severe COVID 19 at the time of recruitment
- •2. Patients not able to consume drugs orally
- •3. Patients with uncontrolled hypertension or diabetes mellitus
- •4. Patients with decompensated liver disease or renal disease
- •5. Pregnancy or lactation
- •6. Patients with multiorgan failure
- •7. Patients undergoing home quarantine during treatment of mild or very mild COVID 19
研究者
相似试验
已完成
不适用
Assessment of indication and efficacy of anti-viral therapy based on mucosal PCR assay in active UC patients with CMV infection.lcerative colitisJPRN-UMIN000022588Department of Gastroenterology and Hepatology, Kyoto University Hospital120
已完成
不适用
Analysis of efficacy and safety of antiviral therapy with daclatasvir and asunaprevir for recurrent hepatitis C after liver transplantatiohepatitis C after liver transplantationJPRN-UMIN000014583Kyoto University Hospital30
已完成
不适用
Analysis of efficacy and safety of antiviral therapy with daclatasvir and asunaprevir for hepatitis C after organ transplantation -Pilot Studyhepatitis C after transplantationJPRN-UMIN000016558Trasnplantation surgery, Hiroshima University Hospital20
招募中
不适用
Analysis of efficacy and safety of antiviral therapy with telaprevir, peginterferon and ribavirin for recurrent hepatitis C after liver transplantatiohepatitis C after liver transplantationJPRN-UMIN000009171Kyoto University Hospital20
招募中
不适用
Analysis of efficacy and safety of antiviral therapy with simeprevir, peginterferon and ribavirin for recurrent hepatitis C after liver transplantatiohepatitis C after liver transplantationJPRN-UMIN000012219Kyoto University Hospital30